PolTREG S.A. (WAR:PTG) — Market Cap & Net Worth
Market Cap & Net Worth: PolTREG S.A. (PTG)
PolTREG S.A. (WAR:PTG) has a market capitalization of $30.80 Million (zł111.92 Million) as of August 1, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #23611 globally and #229 in its home market, demonstrating a 4.35% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PolTREG S.A.'s stock price zł24.00 by its total outstanding shares 4663448 (4.66 Million). See how much does PolTREG S.A. reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
PolTREG S.A. Market Cap History: 2021 to 2026
PolTREG S.A.'s market capitalization history from 2021 to 2026. Data shows change from $88.30 Million to $30.80 Million (-18.33% CAGR).
PolTREG S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PolTREG S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
134.21x
PolTREG S.A.'s market cap is 134.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $88.30 Million | $1.10 Million | -$3.74 Million | 80.35x | N/A |
| 2022 | $59.04 Million | $999.00K | -$1.97 Million | 59.10x | N/A |
| 2023 | $63.92 Million | $1.40 Million | -$13.55 Million | 45.69x | N/A |
| 2024 | $46.97 Million | $350.00K | -$18.71 Million | 134.21x | N/A |
Competitor Companies of PTG by Market Capitalization
Companies near PolTREG S.A. in the global market cap rankings as of August 1, 2026.
Key companies related to PolTREG S.A. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #543 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $477.10 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $762.63 |
| #543 | Argen-X | BR:ARGX | $49.55 Billion | €745.00 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €222.90 |
PolTREG S.A. Historical Marketcap From 2021 to 2026
Between 2021 and today, PolTREG S.A.'s market cap moved from $88.30 Million to $ 30.80 Million, with a yearly change of -18.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł30.80 Million | -2.04% |
| 2025 | zł31.44 Million | -33.06% |
| 2024 | zł46.97 Million | -26.51% |
| 2023 | zł63.92 Million | +8.26% |
| 2022 | zł59.04 Million | -33.14% |
| 2021 | zł88.30 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of PolTREG S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.80 Million USD |
| MoneyControl | $30.80 Million USD |
| MarketWatch | $30.80 Million USD |
| marketcap.company | $30.80 Million USD |
| Reuters | $30.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PolTREG S.A.
Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.